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G
iven their small size, you might 
think that bacteria don’t need to 
be particularly organized: every 
protein would never be too far away from 
where it was needed. In fact, it’s become in-
creasingly clear in recent years that bacterial 
cells are highly ordered, coordinating their 
components in time and space to ensure the 
cells’ rapid and effi  cient proliferation.
Christine Jacobs-Wagner’s studies on 
the polarized bacterium Caulobacter cres-
centus have been central to this sea change 
in the way bacteria are viewed, adapting 
techniques used in eukaryotic cell biology 
to investigate proteins involved in cell 
cycle control, fate determination, and cell 
morphology. Jacobs-Wagner’s interest in 
bacteria began as an undergraduate at the 
University of Liège in her native Belgium, 
and continued as a globe-trotting PhD 
student. Working in several laboratories 
around the world, Jacobs-Wagner demon-
strated that expression of the 
-lactam antibiotic resistance 
gene is induced by the cyto-
plasmic breakdown products 
that accumulate when cell 
wall synthesis is inhibited by 
antibiotics (1).
Jacobs-Wagner was intro-
duced to Caulobacter as a 
postdoc in Lucy Shapiro’s 
laboratory at Stanford Uni-
versity, where she discovered 
that a regulatory kinase 
changed its cellular localization over the 
course of the cell cycle (2). Jacobs-Wagner 
began her own lab at Yale in 2001, where 
she has continued to study how Caulobacter 
polarize (3) and how the polar localization 
of regulatory proteins directs the cell cycle 
and daughter cell fate (4, 5). She is also 
interested in the bacterial cytoskeleton, hav-
ing identifi  ed the prokaryotic equivalent of 
intermediate fi  laments (6) and determined 
how they generate the curved shape of 
Caulobacter cells (7). In a recent inter-
view, Jacobs-Wagner explained why 
studying bacteria fi  ts her personality, and 
how the perception of these organisms 
has changed over the last decade.
LE TOUR
Did you always want to be a scientist?
Absolutely not. I grew up in Belgium, in a 
town near Liège, and when I was young I 
wanted to be a cyclist like Eddy Merckx! 
In high school, I couldn’t decide what I 
wanted to do but ultimately, I chose to 
study biochemistry at university. But even 
then I didn’t know I was going to be a 
researcher. It wasn’t until the third year of 
my PhD that I really got hooked and knew 
I wanted an academic career.
How did you end up studying bacteria?
The last year of my undergraduate degree 
was dedicated to research. I wanted to 
improve my English, so I carried out my 
undergraduate work abroad. Staffan Nor-
mark welcomed me into his lab at Wash-
ington University in St. Louis, and that’s 
where I started with bacteria. There are so 
many interesting things in science that if 
I’d started with something 
else, I probably would have 
continued with that instead, 
but bacteria turned out to 
be the perfect choice for 
me. Because they grow 
fast, you can do a lot of ex-
periments quickly. It fi  ts 
my personality as I’m a lit-
tle impatient! I also like the 
level of complexity in a 
single cell.
Where did you do your PhD?
In fi  ve years, I went to fi  ve different labs 
in four different countries. I stayed in the 
lab at Wash U. for the fi  rst year and then I 
went back to Liège where my supervisor 
was Jean-Marie Frère. Next I spent six 
months in Ted Park’s lab at Tufts Univer-
sity in Boston and a few weeks in Jean 
van Heijenoort’s lab in Paris-Orsay before 
returning to Staffan Normark’s lab, which 
by that time had relocated to the Karolin-
ska Institute in Stockholm.
My philosophy was that, rather than 
continually reinventing the wheel, I’d go 
to the labs that had the right methodologies 
to address the question I was interested in. 
I went there with my samples because I felt 
it would be more productive and I’d learn 
much more. They were some of the best 
years of my life—I loved moving to dif-
ferent places and learning new cultures—
but it was a little disruptive. I wouldn’t want 
my students to travel as much, although 
I encourage them to spend a few months in 
a different lab when possible.
A SCIENTIFICALLY FERTILE 
CRESCENT
Why did you join Lucy Shapiro’s lab for 
your postdoc?
By the end of my PhD I was in love with 
bacteria and wanted to stay in the fi  eld. 
There were so many questions that I thought 
needed answering. I contacted fi  ve different 
people and Lucy’s was the fi  rst lab I inter-
viewed in. I thought that what she was doing 
was so fabulous, and the model system—
Caulobacter crescentus—offered so many 
opportunities, that I canceled my other four 
interviews and signed up with Lucy.
Why is Caulobacter a good model system?
I’m interested in temporal and spatial 
questions, and Caulobacter is really good 
for addressing both. We actually know 
very little about the bacterial cell cycle, 
and  Caulobacter can be synchronized 
using a simple centrifugation technique. 
Then you can monitor the process you’re 
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interested in as the bacteria go through the 
cell cycle. You can synchronize other bac-
teria, but the methods aren’t as easy.
Then there’s Caulobacter’s asymmetry. 
We’re realizing that all bacteria are polar-
ized, but typically only at the molecular 
level, whereas Caulobacter has entire 
appendages—such as the fl  agellum and 
stalk—that form at specifi  c cell poles. In 
addition, it divides asymmetrically to pro-
duce two daughter cells of unequal size 
that have different fates. Symmetry-
breaking mechanisms are a fundamental 
question in biology, but because this is at 
a single-cell level, it’s highly tractable.
But I don’t feel loyalty to Caulobacter. 
We have used other bacterial models on sev-
eral occasions in the past. And right now, 
we’re thinking about some experiments 
that would make more sense for us to do in 
E. coli. I try to use the best system to address 
whatever I fi  nd interesting.
How has bacterial cell biology changed 
in the last decade?
Bacteria were thought of as 
amorphous bags of molecules, 
fl   oating around with no or-
ganization. Now we know that 
they exhibit extensive spatial 
organization that is important 
for many cellular functions. 
There are many processes that 
we didn’t fully understand be-
cause we weren’t aware of the 
cell’s organization.
My perception of bacteria 
changed during my postdoc when I was 
studying a kinase called CckA that regu-
lates the cell cycle. I fused it to GFP and 
went to Rich Losick’s lab to use his fl  uo-
rescence microscope—back to my old 
habit of going wherever I needed to. I 
found that this kinase localized to the cell 
poles, and that its organization changed 
during the cell cycle. The spatial regulation 
really opened our eyes and we realized that 
we had to start looking at proteins in cells 
to really understand their function. Once 
we and others started to do this, it really 
revolutionized the fi  eld.
SHARED APPROACHES
You’re in the Molecular, Cellular and 
Developmental Biology department at 
Yale. Does it benefit your research to 
work with non-bacteriologists?
Absolutely—our questions and approaches 
are similar, so it’s been a tremendous help to 
be surrounded by some fantastic eukaryotic 
cell biologists and microscopists. We’re also 
collaborating with a computational biolo-
gist—Thierry Emonet—as our work is be-
coming more and more quantitative.
One of your ﬁ  rst achievements at Yale 
was the discovery of crescentin—the 
bacterial version of intermediate 
ﬁ  laments. How did that come about?
It was an accident really. My postdoc at the 
time, Nora Ausmees, was doing a visual 
genetic screen for mutants that failed to 
localize proteins to the cell poles. She 
found Caulobacter cells that had lost their 
crescent shape, which we found really in-
triguing. In science, it’s important to keep 
an open mind. If you see something inter-
esting, it can be worth pursuing even if it’s 
not what you were originally looking for.
Caulobacter grows by 
adding cell wall material 
along its length. The os-
motic pressure exerted by 
the cytoplasm stretches the 
cell wall which, in turn, 
facilitates further growth, 
presumably because you 
need to break cell wall 
bonds to incorporate new 
material. Crescentin forms 
a fi  lamentous structure on 
one side of the cell, and we 
think it provides mechanical resistance to 
these stretching forces, so that growth is 
favored on the other side. Over time, this 
leads to the cells becoming curved.
What’s your favorite paper of all the 
ones you’ve published?
The next one is always my favorite! Once 
a paper is in press, I’m already more fas-
cinated by what’s coming next. My stu-
dents and postdocs are fantastic—they 
always come up with something more 
exciting than the work we’ve already done.
What is your lab working on now?
The doubling time of most bacteria is 
remarkably fast, and in that time they have 
to do a lot of important things such as 
growing, replicating, and segregating their 
DNA, and fi  nally dividing. The reason they 
proliferate so well is that they can coordi-
nate all these processes so that they occur at 
the right time and place. We want to under-
stand this temporal and spatial organization. 
In this context, we are also interested in 
cytoskeletal elements that are involved in 
chromosome segregation, cell division, and 
cell morphogenesis. We need to understand 
how they affect these processes and how 
their assembly is regulated.
I read that you used to be an 
accomplished badminton player…
Only by Belgian standards! But yes, I was 
on the international team and was very 
dedicated to the sport, but I ruined my 
shoulder when I was 22 and had to stop 
playing. That was probably a good thing 
for my scientifi  c career because I could 
focus on it more. But I still play sports now. 
I love soccer, running, hiking, and—when 
we’re on vacation—I do kiteboarding.
What do you think you’d be if you 
weren’t a scientist?
I don’t know… I became a scientist a little 
bit by chance, but I still think that if I had 
another life, I’d probably be a scientist 
again because it’s perfect for me. I really 
love it—it’s the absolute best!
1. Jacobs, C., et al. 1997. Cell. 88:823–832.
2. Jacobs, C., et al. 1999. Cell. 97:111–120.
3. Lam, H., et al. 2006. Cell. 124:1011–1023.
4. Angelastro, P.S., et al. 2010. J. Bacteriol. 
192:539–552.
5. Matroule, J.Y., et al. 2004. Cell. 118:579–590.
6. Ausmees, N., et al. 2003. Cell. 115:705–713.
7. Cabeen, M.T., et al. 2009. EMBO J. 28:1208–1219.
A rosette of Caulobacter crescentus cells 
expressing a fluorescent version of the 
asymmetrically localized cell cycle kinase DivJ.
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